U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159386) titled 'Advanced Fibrosis Detection for MASLD in Primary Care' on Aug. 05.
Brief Summary: This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver disease (MASLD) fibrosis risk assessment in primary care patients with MASLD using a stepped wedge, cluster randomized design. This work will generate generalizable data to dramatically enhance MASLD management in primary care.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Metabolic Dysfunction-associated Steatotic Liver Disease
Intervention:
OTHER: EHR alert
Diagnoses ...